Healthcare

AstraZeneca’s (LON: AZN) shares and the latest buzz around

AstraZeneca (LON: AZN), the pharmaceutical major,  which has been news for last some time due to its Covid-19 vaccine, is once again creating buz...

Lens on 5 AIM listed pharma stocks as CMA slaps £260-million fine on...

Summary  CMA slapped fines of over £260 million on drug makers after investigations revealed NHS was overcharged close to a decade for h...

Which are the 10 biggest FTSE-listed healthcare stocks?

Summary The pandemic has made people more aware of the importance of research and development in pharmaceuticals, making Healthcare stocks the flav...

Tristel receives three product approvals in the US, Canada, and Sout...

Summary Tristel received three regulatory approvals for its different categories of product. In the US, the company got approval for surface disin...

More sales, more profits, but less dividends: Emma Walmsley’s roadma...

GlaxoSmithKline’s (LON:GSK) CEO Emma Walmsley has said that by 2031, the company plans to make sales of over £33 billion and increase adju...

EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

The European Union has approved the drug Koselugo, manufactured by AstraZeneca (LON: AZN) and Merck & Co, to treat children above 3 years of age w...

What are the recent business updates unveiled by MyHealthChecked?

Summary MHC had generated revenue of £26,146 from the launch of the COVID-19 PCR nasal swab test kit in December 2020. The Company had repor...

Astrazeneca's Tagrisso Drug Gets Nod for Lung Cancer Treatment

Summary Tagrisso has been approved by the European Commission (EC) to treat patients with early-stage epidermal growth factor receptor-mutated non-...

GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

Summary GSK, Sanofi launched the final phase III trials of their delayed Covid vaccine. The phase III trial for the vaccine have 35,000 people enr...

Vectura Group agrees to £958 million takeover deal by Carlyle Group

Vectura Group PLC (LON: VEC) is the healthcare stock listed on the London stock exchange. VEC’s shares have generated a return of 77.83% in the...

Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyl...

Summary Vectura Group shares rallied very sharply on Wednesday, 26 May, hitting a 4-year high The drugmaker has agreed on the terms of acquisition...

After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine...

Summary The UK has been ranked as world’s top developed country with the best healthcare system overall. Innova, the world’s largest r...

Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

Summary A recent GlobalData survey highlighted a majority of US, and UK healthcare professionals believed the UK is an attractive destination for r...

Vaccination Visibly Helps in Abating Existential Threat to Life

Sumamry As per PHE, the Covid-19 inoculation programme alone has helped in preventing more than 11,000 deaths in England Various medical experts i...

3 Global Pharma Stocks in Focus as UK Enters Talks to Waive Vaccine...

Summary The UK and EU are in talks to waive vaccine patents after the US supported the initiative. India and South Africa have long been asking fo...

Oxford Biomedica Shares Surge as Revenue Expectation from AstraZenec...

Summary Oxford Biomedica on Tuesday almost doubled its revenue expectation from AstraZeneca Plc, as it bagged more batches vaccine order. Biomedic...

GSK-Sanofi Jab Reports Positive Results in Phase 2 Trials

 Summary After an initial setback, the companies reported success for their Covid-19 vaccine candidate. The candidate’s global phase II...

Four Small-Cap Healthcare Stocks That Have Given Over 50 Per Cent Re...

Summary Over the last year, the biotechnology and pharmaceuticals index has been the second-worst performer in the FTSE350 Index. Healthcare stock...

A Glance at 5 Healthcare Penny Stocks

Summary Second phase of coronavirus and new mutations seek advanced healthcare supplies. Vaccine rollout has not affected the demand for test kits...

Vaccine Stocks in News: Pfizer’s Profits Rise, AstraZeneca Faces Opp...

Summary Pfizer predicts US$ 26 billion from sales of Covid-19 vaccine in 2021 Proposed bonus hike for AstraZeneca’s CEO to be opposed by inv...